Evidence map›Paper›PMID 40637654›Full record

Trial reportJACC. Cardiovascular imaging2025

Comparative Prognosis by Stress ECG and Stress Imaging: Results From the ISCHEMIA Trial.

Leslee J Shaw, Lawrence M Phillips, Jonathon Leipsic, Samuel Broderick, Jennifer H Mieres, Thomas H Marwick, Matthias G Friedrich, Todd Miller, Renato D Lopes, Benjamin Chow and 14 more

Registry-linked trialAbstract readRandomized Controlled TrialComparative StudyMulticenter Study
In one paragraph

Trial report in JACC. Cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01471522 (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01471522 nacompletednot on this map

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

TypeinterventionalSponsorNYU Langone HealthRan2012 to 2023Enrolled5,179ConditionsCardiovascular Diseases, Coronary Disease, Coronary Artery Disease, Heart DiseasesArmscardiac catheterization, coronary artery bypass graft surgery, percutaneous coronary intervention, Lifestyle, Medication
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Leslee J ShawIcahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: leslee.shaw@mountsinai.org.
Lawrence M PhillipsNew York University School of Medicine, New York, New York, USA.
Jonathon LeipsicUniversity of British Columbia, Vancouver, British Columbia, Canada.
Samuel BroderickDuke University School of Medicine, Durham, North Carolina, USA.
Jennifer H MieresNorthwell Health, Zucker School of Medicine at Hofstra University, Hempstead, New York, USA.
Thomas H MarwickBaker Heart and Vascular Institute, Melbourne, Australia.
Matthias G FriedrichMcGill University Health Centre, Montreal, Quebec, Canada.
Todd MillerMayo Clinic, Rochester, Minnesota, USA.
Renato D LopesDuke University School of Medicine, Durham, North Carolina, USA.
Benjamin ChowUniversity of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Rodrigo CerciQuanta Diagnóstico por Imagem, Curitiba, Brazil.
Ron BlanksteinBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marcelo DiCarliBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
David J MaronDepartment of Medicine, Stanford University, Stanford, California, USA.
Judith S HochmanNew York University School of Medicine, New York, New York, USA.
Karen P AlexanderDuke University School of Medicine, Durham, North Carolina, USA.
Gregg W StoneIcahn School of Medicine at Mount Sinai, New York, New York, USA.
Sean O'BrienDuke University School of Medicine, Durham, North Carolina, USA.
Bernard R ChaitmanSt Louis School of Medicine Center for Comprehensive Cardiovascular Care, St Louis, Missouri, USA.
Raymond Y KwongBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Michael H PicardMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Daniel S BermanCedars-Sinai Medical Center, Log Angeles, California, USA.
Harmony R ReynoldsNew York University School of Medicine, New York, New York, USA.
ISCHEMIA Research Group

Funding

The Ischemia Trial - CCCU01HL105907 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOCHMAN, JUDITH S · 2011 to 2019
$100.1M
The ISCHEMIA Trial - SDCCU01HL105462 · NHLBI · DUKE UNIVERSITY · PI ALEXANDER, KAREN P, O'BRIEN, SEAN M · 2011 to 2019
$17.8M
THE ISCHEMIA TRIAL - IICCU01HL105561 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHAW, LESLEE J · 2011 to 2018
$6.5M
The ISCHEMIA Trial - EQOLU01HL105565 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2011 to 2017
$2.4M
NHLBI NIH HHS U01 HL105462NHLBI NIH HHS U01 HL105561NHLBI NIH HHS U01 HL105565NHLBI NIH HHS U01 HL105907
6 · The paper itself

Abstract

backgroundLimited contemporary evidence exists on risk prediction by stress imaging and exercise electrocardiography (ECG) among patients with chronic coronary syndromes (CCS). Objectives From the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) study, prognosis was examined by core laboratory-defined stress imaging and exercise ECG findings in CCS patients.

methodsA total of 5,179 patients (qualifying by stress nuclear imaging [n = 2,567], echocardiography [n = 1,085], cardiac magnetic resonance [CMR] [n = 257], and ECG [n = 1,270]) were randomized. Cox models assessed associations between trial endpoints and the number of scarred and ischemic segments, rest/stress left ventricular ejection fraction (LVEF), and ST-segment depression. HRs and 95% CIs were calculated per millimeter, segment, or 5% of LVEF. We examined prognostic models for the following trial endpoints: 1) the trial's primary endpoint of cardiovascular (CV) death, myocardial infarction (MI), resuscitated cardiac arrest, or hospitalization for unstable angina or heart failure; 2) CV death; 3) spontaneous MI; 4) procedural MI; and 5) type 2 MI.

resultsThe number of scarred segments (HR: 1.07 [95% CI: 1.02-1.13]; P = 0.0209), rest LVEF (HR: 0.88 [95% CI: 0.83-0.93]; P < 0.001), and stress LVEF (HR: 0.87 [95% CI: 0.83-0.91]; P < 0.001) predicted the trial's primary endpoint of CV death, MI, resuscitated cardiac arrest, or hospitalization for unstable angina or heart failure. The extent of scar and rest/stress LVEF on echocardiography and nuclear imaging predicted several trial endpoints. The number of ischemic segments predicted spontaneous (HR: 1.08 [95% CI: 1.03-1.14]; P = 0.0104) and procedural MI (HR: 1.14 [95% CI: 1.03-1.25]; P = 0.0015) but was of borderline significance for the trial's primary endpoint (P = 0.0746). Ischemia extent by CMR predicted the trial's primary endpoint (P = 0.0068) and spontaneous MI (P = 0.0042).

conclusionsISCHEMIA trial findings from 320 worldwide centers revealed that stress imaging and exercise ECG measures exhibited a variable association with key trial endpoints delineating risk patterns for ischemia and infarction. Stress CMR ischemia predicted several trial endpoints, supporting an expanded role in the evaluation of patients with CCS (ISCHEMIA [International Study of Comparative Health Effectiveness With Medical and Invasive Approaches]; NCT01471522).

Indexed as

Echocardiography, StressElectrocardiographyExercise TestTomography, Emission-Computed, Single-PhotonAgedChronic DiseaseFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMyocardial InfarctionPredictive Value of TestsPrognosisProportional Hazards ModelsRisk Assessmentchronic coronary syndromesischemiamultimodality imagingprognosis

Identifiers

PMID40637654
PMCPMC12252255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.